Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non-Small Cell Lung Cancer

被引：148
|
作者：
Hong, Shaodong [1 ,2 ,3 ]
Gao, Fangfang [1 ,2 ,3 ]
Fu, Sha [4 ]
Wang, Yan [5 ]
Fang, Wenfeng [1 ,2 ,3 ]
Huang, Yan [1 ,2 ,3 ]
Zhang, Li [1 ,2 ,3 ]
机构：
[1] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Dept Pathol, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[5] Quest Genom, Nanjing, Jiangsu, Peoples R China
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 05期
基金：
国家重点研发计划;
关键词：
CHEMOTHERAPY; METAANALYSIS; IMPACT;
D O I：
10.1001/jamaoncol.2018.0049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：739 / 742
页数：5
相关论文
共 50 条
  • [41] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Non-Small Cell Lung Cancer With Uncommon Mutations
    Kanazu, Masaki
    Naoki, Yoko
    Shiroyama, Takayuki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Omachi, Naoki
    Okishio, Kyoichi
    Suzuki, Hidekazu
    Okamoto, Norio
    Morishita, Naoko
    Hirashima, Tomonori
    Atagi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [42] Comparison of the Time-to-response Between Radiotherapy and Epidermal Growth Factor Receptor - Tyrosine Kinase Inhibitors for Advanced Non-small Cell Lung Cancer with EGFR Mutation
    Imai, Hisao
    Shukuya, Takehito
    Takahashi, Toshiaki
    Fujiwara, Sakae
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Harada, Hideyuki
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    ANTICANCER RESEARCH, 2013, 33 (08) : 3279 - 3284
  • [43] Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wildtype non-small cell lung cancer?
    Arriola, Edurne
    Taus, Alvaro
    Casadevall, David
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (04): : 45 - 56
  • [44] Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
    Normanno, N.
    Rachiglio, A. M.
    Lambiase, M.
    Fenizia, F.
    Iannaccone, A.
    Chicchinelli, N.
    Morabito, A.
    Montanino, A.
    Rocco, G.
    Galetta, D.
    Montagna, S.
    Crino, L.
    Ludovini, V.
    Vincenzi, B.
    Barletta, E.
    Pinto, C.
    Ferrau, F.
    Botti, G.
    Piccirillo, M. C.
    Perrone, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [45] Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
    Normanno, N.
    Rachiglio, A. M.
    Lambiase, M.
    Fenizia, F.
    Iannaccone, A.
    Chicchinelli, N.
    Morabito, A.
    Rocco, G.
    Galetta, D.
    Montagna, E. S.
    Crino, L.
    Ludovini, V.
    Vincenzi, B.
    Barletta, E.
    Pinto, C.
    Ferrau, F.
    Botti, G.
    Piccirillo, C.
    Perrone, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies
    Johnson, Melissa
    Garassino, Marina Chiara
    Mok, Tony
    Mitsudomi, Tetsuya
    LUNG CANCER, 2022, 170 : 41 - 51
  • [47] Tyrosine Kinase-Inhibitors effective in epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCL)
    Pommer, Peter
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (18) : 1284 - 1284
  • [48] A pilot study of anlotinib with third-generation epidermal growth factor receptor tyrosine kinase inhibitors in untreated EGFR- mutant patients with advanced non-small cell lung cancer
    Li, Ting
    Chang, Kejie
    Qiu, Xin
    Lai, Zhirong
    Luo, Yuanling
    Chen, Jiaqun
    Lv, Weize
    Lin, Zhong
    Pei, Xiaofeng
    Wu, Xiangwen
    Wang, Xiaojin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (06) : 1256 - 1263
  • [49] Vascular endothelial growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small cell lung cancer
    Spagnuolo, A.
    Palazzolo, G.
    Sementa, C.
    Gridelli, C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (04) : 491 - 506
  • [50] Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)
    Sun, Xin
    Xu, Shan
    Yang, Zunhua
    Zheng, Pengwu
    Zhu, Wufu
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (03) : 223 - 238
12345